Chao Xingjuan 4

4 · Ceribell, Inc. · Filed May 7, 2026

AI-generated summary of this filing

Updated May 7, 2026

Ceribell (CBLL) CEO Chao Sells Shares, Exercises Options

What Happened

Chao Xingjuan, President, CEO and Director of Ceribell, exercised options and sold shares on May 5, 2026. She exercised 25,000 option shares at $4.70 each (total exercise cost $117,500) and sold a total of 39,000 common shares in open-market/private sales for aggregate proceeds of approximately $783,974. The sales were executed at weighted-average prices of about $20.09–$20.12 per share (range $19.77–$20.48).

Key Details

Transaction date: May 5, 2026; Form 4 filed May 7, 2026 (within normal reporting window).
Options exercised: 1,446 shares @ $4.70 ($6,796) and 23,554 shares @ $4.70 ($110,704) — total exercised = 25,000 shares; two additional derivative entries show $0 disposals tied to the exercises.
Shares sold: 14,000 @ $20.12 ($281,680), 1,446 @ $20.12 ($29,094), 23,554 @ $20.09 ($473,200) — total sold = 39,000 shares; total sale proceeds ≈ $783,974. Weighted-average sale price reported; individual trades ranged $19.77–$20.48.
Net proceeds before taxes/fees (sale proceeds minus exercise cost): ≈ $666,474.
Footnotes: trades were made pursuant to a Rule 10b5-1 trading plan (F1); co-trustee/co‑beneficial ownership and disclaimer notes appear (F3, F4); one grant vests monthly (F5) and another option is fully vested/currently exercisable (F6).
Shares owned after the transactions are not specified in the provided excerpt.

Context

This sequence (exercising options then selling shares) is commonly a cashless or monetization event: options converted to common shares and many of those shares were sold the same day under a 10b5‑1 plan. Such transactions are routine for insiders exercising vested awards and do not, by themselves, indicate the insider’s view of the company’s outlook.

Form 4

Period: 2026-05-05

DirectorPresident and CEO

Transactions

Sale
Common Stock
[F1][F2]
2026-05-05$20.12/sh−14,000$281,680→ 836,347 total
Exercise/Conversion
Common Stock
[F1]
2026-05-05$4.70/sh+1,446$6,796→ 837,793 total
Sale
Common Stock
[F1][F2]
2026-05-05$20.12/sh−1,446$29,094→ 836,347 total
Exercise/Conversion
Common Stock
[F1]
2026-05-05$4.70/sh+23,554$110,704→ 859,901 total
Sale
Common Stock
[F1][F2]
2026-05-05$20.09/sh−23,554$473,200→ 836,347 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]
2026-05-05−1,446→ 291,602 total
Exercise: $4.70Exp: 2033-02-16→ Common Stock (1,446 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F6]
2026-05-05−23,554→ 125,031 total
Exercise: $4.70Exp: 2033-02-16→ Common Stock (23,554 underlying)

Holdings

Footnotes (6)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77 to $20.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
[F3]The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
[F4]The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
[F5]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F6]The stock option is fully vested and currently exercisable.

Signature

/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao|2026-05-07

1 file